| |
|
|
Korea United Pharm. Inc. (033270) |
|
|
STOCK |
|
|
|
  |
(unit : Won, Share) |
| Fiscal Year End |
07.03 | 07.12 | 08.12 | 09.09 |
| Par Value |
500 | 500 | 500 | 500 |
| Yearly Highest Price |
4,060 | 4,480 | 4,200 | 9,110 |
| Yearly Lowest Price |
1,825 | 3,030 | 2,210 | 2,430 |
| Common Shares O/S |
15,025,924 | 15,025,924 | 15,025,924 | 15,025,924 |
| Preferred Shares O/S |
- | - | - | - |
| Market Cap.(100Mn.Won) |
596 | 491 | 365 | 1,167 |
| Dividends (%) |
10.0 | 10.0 | 12.0 | - |
|
 |
(Company/Sector/Market) |
| |
2008.06 | 2009.06 |
| Beta |
0.64 / 0.68 / 1.00 | 0.71 / 0.54 / 1.00 |
| Volatility |
35.39 / 23.43 / 26.01 | 61.49 / 32.47 / 41.28 |
|
 |
(unit : Won) |
| Fiscal Year End |
07.03 | 07.12 | 08.12 | 09.09 |
| Earnings Per Share |
272 | 380 | 603 | 1,144 |
| Sales Per Share |
4,648 | 4,065 | 6,434 | 7,882 |
| Book Value Per Share |
2,570 | 2,913 | 3,512 | 4,369 |
| Cash Flow Per Share |
670.38 | 231.77 | 479.20 | 1,185.21 |
|
 |
(Unit : Times) |
| Fiscal Year End |
07.03 | 07.12 | 08.12 | 09.09 |
| Price / Earnings (H/L) |
14.93/6.71 | 11.79/7.97 | 6.97/3.67 | 7.96/2.12 |
| Price / Sales (H/L) |
0.87/0.39 | 1.10/0.75 | 0.65/0.34 | 1.16/0.31 |
| Price / Book (H/L) |
1.58/0.71 | 1.54/1.04 | 1.20/0.63 | 2.08/0.56 |
| Price / Cash Flow (H/L) |
6.06 / 2.72 | 19.33 / 13.07 | 8.76 / 4.61 | 7.69 / 2.05 |
|
 |
(Unit : 100Mn.Won, %) |
| Fiscal Year End |
06.03 |
07.03 |
07.12 |
08.12 |
| Company |
Sector |
Company |
Sector |
Company |
Sector |
Company |
Sector |
| Invested Capital |
513 |
714 |
509 |
708 |
529 |
708 |
594 |
942 |
| NOPLAT |
35 |
54 |
66 |
60 |
56 |
60 |
107 |
71 |
| Return on Invested Capital |
6 |
7 |
13 |
8 |
10 |
8 |
18 |
7 |
| WACC |
6 |
6 |
6 |
6 |
5 |
6 |
6 |
6 |
| Economic Value Added |
2.0 |
8.6 |
31.5 |
10.9 |
24.6 |
10.9 |
68.0 |
5.3 |
|
 |
(Unit : 100Mn.Won, Times) |
| Fiscal Year End |
2007.03 | 2007.12 | 2008.12 | 2009.09 |
| Enterprise Value(EV) |
744.79 | 648.14 | 494.03 | 1,318.24 |
| EBITDA |
103.00 | 96.86 | 159.30 | 232.92 |
| EBITDA/Sales |
0.15 | 0.16 | 0.17 | 0.20 |
| EBITDA/Financial Exp. |
5.58 | 7.41 | 8.51 | 15.21 |
| EV/EBITDA |
7.23 | 6.69 | 3.10 | 5.66 |
|
|
|
|
